NadiaKarenMalikMD
Radiation Oncology • Buffalo, NYAssistant Professor, Radiation Oncology Director of Thoracic and Hepatobiliary/Pancreas Program Roswell Park Comprehensive Cancer Center
Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8254
Summary
- Dr. Nadia Malik graduated from Northeast Ohio Medical University and completed her residency in Radiation Oncology in 2012 at Roswell Park Cancer Institute. She is board certified in radiation oncology and has several publications in reputable journals. She recently returns from working as a Consultant Radiation Oncologist at the American Hospital, Dubai, UAE where she helped lead the first SBRT program in the region. She returns to Roswell Park as a Clinical Assistant Professor. She is committed to providing the best oncology care for her patients and to promote awareness in the region.
Education & Training
University at BuffaloResidency, Radiation Oncology, 2008 - 2012
Loyola University Medical CenterInternship, Internal Medicine, 2007 - 2008
Northeast Ohio Medical UniversityClass of 2007
State University of New York at BuffaloB.A., English, Cum Laude, 2002
Certifications & Licensure
NY State Medical License 2012 - 2025
FL State Medical License 2017 - 2019
IN State Medical License 2013 - 2017
IL State Medical License 2007 - 2014- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Walter T. Murphy Teaching Award Roswell Park Cancer Institute, 2015
- ABS LDR Prostate Brachytherapy Scholarship Long Island Jewish Medical, 2013
- Delegate of the Royal College of Physicians (RCP) Educator Program SUNY Buffalo, 2013
Publications & Presentations
PubMed
- 3 citationsAssociation of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy.Karen Huang, Sharan Prasad, Sung Jun Ma, Han Yu, Austin J Iovoli
BMC Cancer. 2023-03-18 - 7 citationsThe evolving role of radiation in pancreatic cancer.Midhun Malla, Fatemeh Fekrmandi, Nadia Malik, Hassan Hatoum, Sagila George
Frontiers in Oncology. 2022-01-01 - 3 citationsBrachial Plexopathy After Single-Fraction Stereotactic Body Radiation Therapy in Apical Lung Tumors.Austin J Iovoli, Sharan Prasad, Harish K Malhotra, Nadia K Malik, Simon Fung-Kee-Fung
Practical Radiation Oncology. 2022-12-26
Abstracts/Posters
- Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancerG Yang, N Malik, R Chandrasekhar, W Ma, L Flaherty, R Iyer, B Kuvshinoff, J Gibbs, G Wilding, G Warren, K Salerno, Multiple presentations, 1/1/2013
- Outcomes in patients 65 years or older treated with trimodality therapy for esophageal carcinomaN.K. Malik, S. Patil, A. Groman, H. Nava, S. Yendamuri, S. Nurkin, T. Sher, G. Warren, G. Yang, K. May, ASTRO, 1/1/2011
- Outcomes and Tolerability of Treatment for Locally Advanced Pancreatic Cancer Patients 65 Years or OlderN.�K.�Malik,�K.�May,�A.�Groman,�S.�Patil,�J.�Gibbs,�B.�Kuvshinoff,�W.�Ma,�R.�Iyer,�G.Warren,�G.Yang, ASTRO, 1/1/2011
- Join now to see all
Lectures
- Establishing local confidence limit and optimization of VMAT patient specific quality assuranceAmerican Hospital, Dubai, UAE - 1/1/2017
- Treatment of Locally Advanced Unresectable Pancreatic Cancer: A 10-year experience1/1/2012
- Response based outcomes in esophageal cancer patients treated with primarily non cisplatin and 5-fluorouracil based trimodality therapy1/1/2011
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
